Ashlyna Kit
Product Images NDC 68462-646

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Ashlyna (NDC 68462-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinylestradiol

FDA Label Image

Figure1

FDA Label Image

Levonorgestrel

FDA Label Image

Blistercard

FDA Label Image

Figure 2

Figure 2
This text appears to be a description of different methods of birth control and their effectiveness. The text includes information on the number of pregnancies per 100 women in one year using various methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring hormones, condoms, diaphragm, and spermicide. The text also suggests the option of not having sex during the most fertile days of the monthly cycle, as well as using the withdrawal method. The information provided is focused on giving options for preventing pregnancies.*
FDA Label Image

Figure2

FDA Label Image

Logo (Image 01)

FDA Label Image

Logo (Image 02)

Logo (Image 02)
Ashlyna® is a contraceptive manufactured by Glenmark Pharmaceuticals Limited in India for Glenmark Pharmaceuticals Inc in the US. It contains Levonorgestrel and Ethinyl Estradiol and comes in a package that is not child-resistant. The product prevents pregnancy but does not protect against sexually transmitted diseases. It contains 91 tablets, 84 light blue to blue tablets with 0.15 mg of levonorgestrel and 0.03 mg of ethinyl estradiol, and 7 light yellow to yellow tablets with 0.01 mg of ethinyl estradiol each. It should be taken one tablet daily for 91 consecutive days, in a specific order as prescribed. It should be stored between 20°C to 25°C, protected from light, and comes with patient information that should be delivered to the user. Blister cards should not be sold separately.*
FDA Label Image
Logo
This appears to be a brand name or a proper name. Glenmark is a pharmaceutical company that specializes in the development and manufacturing of affordable and innovative medicines for the treatment of various medical conditions such as diabetes, cardiovascular disease, respiratory illness, etc.*
FDA Label Image

Logo1

Logo1
This text is not enough to generate a useful description. It seems to only include a company name - Glenmark - which might be related to the pharmaceutical industry. Without further context, it is not possible to provide a comprehensive description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.